• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medpace Hires Executive to Open Bioanalytical Lab in Fall

Medpace Hires Executive to Open Bioanalytical Lab in Fall

August 5, 2008
CenterWatch Staff

Cincinnati-based Medpace, a global contract research organization (CRO), has hired Yong-Xi Li as Executive Director of its new Medpace Bioanalytical Laboratories. This new laboratory is projected to open in fall of 2008 and will complement services provided by other Medpace research facilities, such as Medpace Clinical Pharmacology and Medpace Reference Laboratories.

Dr. Li joins Medpace with a strong background in bioanalytical technology, method development, validation, and sample analysis in support of pharmaceutical development and both preclinical and clinical studies.

At Medpace, Dr. Li will direct operations and activities of the new, advanced mass spectrometry Medpace Bioanalytical Laboratories, including bioanalytical aspects for small and large drug molecules according to GLP and GMP compliances and ICH guidelines.

Dr. Li comes to Medpace from Eurofins Scientific, NJ, where he served as Senior Director, managing its laboratory process and facilitating bioanalytical technology and methods. Prior to his work at Eurofins Scientific, Dr. Li was the Vice President of Ricerca and then the Vice President of XenoBiotic Laboratories, where he led and expanded the bioanalytical laboratories and activities.

Dr. Li arrived in the United States and worked as a senior research scientist under Dr. K.J. Klubende and Dr. B.H. Davis to establish his first bioanalytical laboratory. He went on to do postdoctoral studies in Chemistry at Cornell University, Baker Laboratory, in Ithaca, New York.

“We are excited to have an experienced chemist such as Yong-Xi Li on staff,” said August Troendle, M.D., Medpace’s CEO.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing